Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Retained Earnings (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Retained Earnings for 11 consecutive years, with -$250000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 99.98% year-over-year to -$250000.0, compared with a TTM value of -$250000.0 through Dec 2025, up 99.98%, and an annual FY2025 reading of -$250000.0, up 99.98% over the prior year.
  • Retained Earnings was -$250000.0 for Q4 2025 at Wave Life Sciences, up from -$1.3 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at $269000.0 in Q1 2021 and bottomed at -$1.3 billion in Q3 2025.
  • Average Retained Earnings over 5 years is -$386.6 million, with a median of -$171500.0 recorded in 2023.
  • The sharpest move saw Retained Earnings soared 100.04% in 2021, then plummeted 3533865.52% in 2023.
  • Year by year, Retained Earnings stood at $181000.0 in 2021, then plummeted by 116.02% to -$29000.0 in 2022, then tumbled by 3533865.52% to -$1.0 billion in 2023, then fell by 9.47% to -$1.1 billion in 2024, then soared by 99.98% to -$250000.0 in 2025.
  • Business Quant data shows Retained Earnings for WVE at -$250000.0 in Q4 2025, -$1.3 billion in Q3 2025, and -$161000.0 in Q2 2025.